News · Immunology
996 stories
Oct 15, 26AstraZeneca inks $1.5B insitro deal for AI-enabled target discovery of liver, heart disease drugs
Oct 14, 26Why OMass’ $310M series C marks ‘fantastic milestone’ on journey to become ‘Britain’s Big Biotech’
Oct 13, 26Vir CEO sees ‘opportunity to do more deals’ after striking $1.9B Gilead pact for dual-masked TCEs
Oct 13, 26BioNTech’s mRNA cancer vaccine fails phase 3 test, significantly denting analysts’ confidence
Oct 11, 26The 2026 Biotech Graveyard